Skip to main content
Clinical Trials/CTRI/2021/03/031781
CTRI/2021/03/031781
Completed
Phase 3

To compare the analgesic efficacy of ultrasound guided PEC II block using dexamethasone as an adjuvant to ropivacaine vs plain ropivacaine in patients undergoing modified radical mastectomy: a prospective, randomized, double blind, parallel group controlled clinical trial.

Dr Porika Prashanth Nayak0 sites64 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Dr Porika Prashanth Nayak
Enrollment
64
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 29, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Porika Prashanth Nayak

Eligibility Criteria

Inclusion Criteria

  • 1\)Female patients aged 18 years and above
  • 2\)Posted for unilateral elective MRM
  • 3\)Belonging to American society of Anaesthesiologists (ASA) grade I, II, III

Exclusion Criteria

  • 1\)Patients refusal.
  • 2\)Contraindications to regional anesthesia (RA) (bleeding diathesis, infection at the site of block and peripheral neuropathy).
  • 3\)Allergy to study drugs.
  • 4\)BMI ââ?°Â¥ 35 kg/m2 or body weight ââ?°Â¤ less than 40kg.
  • 5\)Chest wall deformity.
  • 6\)Patients who have undergone prior breast surgery.
  • 7\)Psychiatric patients.
  • 8\)Pregnant and lactating patients.
  • 9\)Any untoward major intra\-operative complication (if any). (severe hypotension, bradycardia any injury to the nerve related to the block)

Outcomes

Primary Outcomes

Not specified

Similar Trials